10x Genomics (TXG) Short term Debt (2018 - 2019)
10x Genomics' (TXG) quarterly Short term Debt came in at $9.9 million in Q4 2019, up 136.02% year-on-year from $4.2 million in Q4 2018, and up 33.85% quarter-over-quarter from $7.4 million in Q3 2019.
10x Genomics (TXG) Short term Debt (2018 - 2019) Analysis & Trends
10x Genomics has disclosed Short term Debt across 2 years of filings, most recently posting $9.9 million for Q4 2019.
- Short term Debt for Q4 2019 came in at $9.9 million, up 136.02% year-over-year; the trailing twelve-month figure through Dec 2019 was $9.9 million (up 136.02% YoY), and the FY2019 annual result was $9.9 million, up 136.02% from the prior year.
- Short term Debt came in at $9.9 million for Q4 2019 at 10x Genomics, up from $7.4 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $9.9 million in Q4 2019 to a low of $4.2 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Teladoc Health | 1.45 Bn | 696.57 Mn | 562.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 9.88 Mn |
| Sep 30, 2019 | 7.38 Mn |
| Dec 31, 2018 | 4.19 Mn |